SELLING CANNABIS FOR MEDICAL PURPOSE: MUHAMMAD LUKMAN MOHAMAD v PP [2021] 7 CLJ 524
1. INTRODUCTION
During the administration of Pakatan Harapan, there were proposals and reforms to the status and authorisation of cannabis by the Government. However, there was no clear decision on those matters. On 18 February 2021, the ex-Prime Minister for Tan Sri Muhyiddin Yassin stated that the Government would maintain the current status on cannabis as enforced by the Dangerous Drugs Act 1952.
Despite the status of cannabis in current law being unchanged, can we sell the cannabis with the good intention to cure patients of various ailments? Muhammad Lukman Mohamad v. PP [2021] 7 CLJ 524 answers this question.
2. WHAT HAPPENED?
The Appellant, in this case, was an online seller of medical cannabis. On 7 December 2015, a house in Banting, Selangor, was raided by a police team where it was found apparatus for smoking drugs, bottles filled with cannabis oil and drugs in different areas of the house. The Appellant claimed that he did not know that drugs were in his house but admitted that he knew the oil was cannabis. He asserted that the oil was used for medical purposes and to be sold online on the website “Health-Care.”
3.WHAT WAS THE APPELLANT’S ARGUMENT?
The learned counsel for the Appellant argued that the Appellant was selling medical online to help cure various illnesses. Further, it was argued that the Appellant’s conduct should be differentiated from other drug dealers that exploit the vulnerability of drug addicts.
4.HOW DID THE COURT DECIDE?
The Federal Court (per Mohd Zawawi Saleh FCJ) upheld the decision of the High Court and the Court of Appeal that the Appellant’s conduct is still within the ambit of Dangerous Drugs Act 1952 as there is no amendment to remove cannabis which is a controlled drug from First Schedule of Dangerous Drug Act 1952.
Further, the Appellant did not obtain any authorisation from the Minister of Health to possess, manufacture, handle, process, or sell the impugned cannabis for medical purposes.
5. CONCLUSION
There is no distinction between “hemp” and “marijuana” in the Dangerous Drugs Act 1952. Both terms are different names for cannabis which contains different chemicals. As there is no amendment on DDA, only registered medical practitioners under the Medical Act 1971 and registered pharmacists who have Type A licenses can sell and supply cannabis for medical treatment.
Reference:
- MUHAMMAD LUKMAN MOHAMAD v PP [2021] 7 CLJ 524
- https://codeblue.galencentre.org/2021/11/09/health-ministry-permits-marijuana-for-medical-treatment/
Good job, done well. Write more.
ReplyDelete